James V. Freeman, MD, MPH, MS
Professor of Medicine (Cardiovascular Medicine)Cards
About
Titles
Professor of Medicine (Cardiovascular Medicine)
Director, Cardiac Electrophysiology Laboratories, Yale Medicine
Positions outside Yale
Director, Yale Atrial Fibrillation Program, Yale Medicine, Yale University
Biography
I am a clinical cardiac electrophysiologist with a focus on the ablation of complex arrhythmias (supraventricular tachycardias, atrial fibrillation and flutter, and ventricular tachycardia), and left atrial appendage occlusion. I am Director of the Cardiac Electrophysiology Laboratories for Yale New Haven Health and the Director of the Yale Atrial Fibrillation Program. I am also interested in implantable cardiac devices for cardiac arrhythmias and heart failure, including pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices. I have a Masters of Public Health degree with a concentration in biostatistics and epidemiology from Johns Hopkins and a Masters of Science degree in health services research from Stanford. I have published extensively on topics of comparative effectiveness, cost-effectiveness and clinical outcomes with cardiac arrhythmias. I have research funding from the National Institutes of Health and the American College of Cardiology to study the safety and effectiveness of therapies for the prevention and treatment of atrial fibrillation, ventricular fibrillation/tachycardia, sudden cardiac death, stroke and heart failure.
Appointments
Cardiovascular Medicine
ProfessorPrimary
Other Departments & Organizations
- Cardiovascular Medicine
- Center for Outcomes Research & Evaluation (CORE)
- Electrophysiology & Cardiac Arrhythmia Program
- Internal Medicine
- Sports Cardiology Program
- Yale Medicine
- Yale Ventures
Education & Training
- Fellowship
- Stanford University Hospital and Clinics (2013)
- MS
- Stanford University School of Medicine, Health Services Research (2011)
- American Heart Association Cardiovascular Outcomes Research Fellow
- Kaiser Permanence of Northern California (2011)
- Fellowship
- Stanford University Hospital and Clinics (2010)
- Adjunct Clinical Instructor, Hospitalist
- Stanford University Hospital and Clinics (2007)
- Residency
- Stanford University Hospital and Clinics (2006)
- MD
- Johns Hopkins University School of Medicine (2003)
- MPH
- Johns Hopkins University Bloomberg School of Public Health
- BA
- Dartmouth College, Biochemistry and Molecular Biology/English
Research
Overview
1) Comparative effectiveness of catheter ablation vs medical therapy for atrial fibrillation
2) Safety and Effectiveness of Left Atrial Appendage Closure in Atrial Fibrillation I and II (SAFELY- AF)
2) Symptoms associated with atrial fibrillation in patients in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
3) Contemporary comparative effectiveness of implantable cardioverter-defibrillators vs medical therapy for decreasing mortality
Medical Research Interests
Public Health Interests
Clinical Care
Overview
James V. Freeman MD, MPH, MS, is a cardiologist who specializes in the treating cardiac arrhythmias. He is nationally known for his expertise performing specialized arrhythmia procedures including ablation of complex arrhythmias (supraventricular tachycardias, atrial fibrillation and flutter, and ventricular tachycardia), left atrial appendage occlusion, and placing implantable cardiac devices such as pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices.
Dr. Freeman is director of the Cardiac Electrophysiology Laboratories for Yale New Haven Health and the director of the Yale Atrial Fibrillation Program. He has a Masters in Public Health degree with a concentration in biostatistics and epidemiology from Johns Hopkins and a Masters of Science degree in health services research from Stanford.
Dr. Freeman has published extensively on topics of comparative effectiveness, cost-effectiveness, and clinical outcomes with cardiac arrhythmias. He has served as the lead researcher on studies funded by the National Institutes of Health, the American College of Cardiology, and the American Heart Association to study the safety and effectiveness of therapies for the prevention and treatment of atrial fibrillation, ventricular fibrillation/tachycardia, sudden cardiac death, stroke and heart failure.
Clinical Specialties
Fact Sheets
Atrial Fibrillation
Learn More on Yale MedicineAtrial Flutter
Learn More on Yale MedicineAtrioventricular Block
Learn More on Yale MedicineMinimally Invasive Surgery
Learn More on Yale Medicine
Board Certifications
Clinical Cardiac Electrophysiology
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2019
- Original Certification Date
- 2014
Yale Medicine News
News
News
- October 24, 2024
New Analytics Center for Cardiovascular Medicine
- September 13, 2024Source: TCTMD
TCTMD's Quick Takes: James Freeman
- August 27, 2024Source: TCTMD
Dropping Aspirin From Post-LAAO Regimens Seems Like a Good Idea
- September 14, 2023
Electronic Health Record Strategies Can Improve Care of Patients with Heart Failure